US, European Regulators Set Principles for 'Good AI Practice' in Drug ...

EMA and FDA agree 'principles' for AI in drug development

The FDA and EMA have come up with guiding principles that they say will underpin future guidance on the use of AI technologies in drug development.

USFDA, EMA Issue First Joint Guidelines on Safe Use of AI in Drug Development

The move comes as regulators push to expand the use of AI in drug discovery and development to shorten timeline and reduce animal testing.

EMA and FDA Collaborate on Framework for AI Use in Drug Development

FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and innovation across the life cycle of a drug.

US, European regulators set principles for 'good AI practice' in drug ...

AI drug creation guidelines released by the FDA

Drug manufacturers' use of AI has recently increased significantly, according to the FDA. Here's how the agency says the technology can be safely implemented.

EU And US Regulators Reach Landmark Accord On AI Principles In Drug Development

The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have jointly established new AI principles in drug development to reduce regulatory divergence between the major markets of the European Union and the United States. Industry associations have applauded the landmark accord, as it strengthens harmonisation across the regions – but emphasise […]